Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments
Pandemic of coronavirus disease (COVID-19) is still pressing the healthcare systems worldwide. Thus far, the lack of available COVID-19-targeted treatments has led scientists to look through drug repositioning practices and exploitation of available scientific evidence for potential efficient drugs...
Enregistré dans:
Auteurs principaux: | , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c8e11f03c1724e42be50bdc78ade76c4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|